Anti-Aging · Reference
Can You Take Sermorelin With Tirzepatide or Semaglutide?
This page covers why the pairing is used, what each medication does, what is and is not known about taking them together, the products that matter, which side effects belong to which, what not to stack, and how to add sermorelin properly. Everything here applies to semaglutide the same way.

Sermorelin can be prescribed alongside tirzepatide or semaglutide, and when it is, the reason is usually lean tissue rather than more weight loss. Tirzepatide and semaglutide reduce appetite through gut-hormone receptors; sermorelin is a growth-hormone-releasing hormone analogue that prompts your pituitary to release its own growth hormone, and it is not a weight-loss medication. No trial has tested the combination, and no trial shows that a growth hormone secretagogue preserves muscle during GLP-1 treatment. The one interaction worth knowing is glucose: growth hormone reduces insulin sensitivity while GLP-1 medications act the other way, so your physician watches it across both.
This page covers why the pairing is used, what each medication does, what is and is not known about taking them together, the products that matter, which side effects belong to which, what not to stack, and how to add sermorelin properly. Everything here applies to semaglutide the same way.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
The short answer
| Question | Answer |
|---|---|
| Can sermorelin be taken with tirzepatide or semaglutide? | Yes, they are sometimes prescribed together after a physician reviews your intake |
| Why pair them? | The GLP-1 addresses appetite and weight; sermorelin is added by some prescribers with lean tissue in mind, alongside training and protein |
| Has the combination been studied? | No |
| Does sermorelin add weight loss? | No. Its trials that measured body composition did not show weight loss |
| What gets watched? | Glucose, because the two push it in opposite directions |
| What not to do | Add a second GHRH analogue such as CJC-1295 or tesamorelin on top, or take semaglutide and tirzepatide together |
| Product | What is in it | Price |
|---|---|---|
| Sermorelin | 5 mL vial, sermorelin 2 mg/mL (10 mg per vial); also a 3 mL Pen cartridge containing 9 mg | $229/mo |
| Ipamorelin + Sermorelin | 5 mL vial, ipamorelin 2 mg/mL + sermorelin 2 mg/mL (10 mg of each) | $219/mo |
| Tirzepatide | Dose-specific 2 mL vials, 10 mg to 60 mg | From $159/mo |
| Semaglutide | Dose-specific vials, 1 mg to 10 mg | From $99/mo |
Every figure is an all-in monthly price covering medication, physician review, refill management and shipping, with no separate membership fee. Pepti is cash-pay and does not bill insurance. Current pricing always lives on each product page.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
Why anyone pairs sermorelin with a GLP-1
Weight lost on a GLP-1 is not all fat
In the STEP 1 body-composition substudy of semaglutide, both fat mass and lean mass fell, though fat fell by more and the proportion of lean mass rose. Strong appetite suppression also makes under-eating protein easy. Losing muscle along with fat is the honest rationale for adding a growth-hormone-axis peptide: something aimed at lean tissue, used with resistance training and a protein target rather than instead of them.
What sermorelin is
Sermorelin is a 29-amino-acid analogue of growth-hormone-releasing hormone (GHRH), the signal the hypothalamus sends to the pituitary. It binds the GHRH receptor and prompts a short pulse of your own growth hormone, with feedback from somatostatin and IGF-1 still in place. It contains no growth hormone, it is not an anabolic steroid, and it is not a GLP-1 medication. It was once the active ingredient of an FDA-approved drug for children with growth hormone deficiency, discontinued by its manufacturer in 2008 for commercial reasons; in 2013 the FDA determined the withdrawal was not for reasons of safety or effectiveness. More is in what is sermorelin.
What the sermorelin trials found on body composition
Study Who What it measured Johns Hopkins, Metabolism, 1997 11 healthy men aged 64 to 76, nightly for six weeks Nocturnal growth hormone rose, IGF-1 did not; weight, body composition, glucose, insulin and lipids were unchanged UC San Diego, Journal of Clinical Endocrinology and Metabolism, 1997 19 men and women aged 55 to 71, a related GHRH(1-29) analogue nightly for 16 weeks IGF-1 rose, then drifted toward baseline; lean body mass rose in men, not women; weight did not change That is the evidence a pairing with a GLP-1 rests on: small trials in healthy older adults, measuring hormones and body composition, with a lean-mass change in men only. None was done alongside a GLP-1, and none measured weight loss as an outcome.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
How the two compare
| Tirzepatide or semaglutide | Sermorelin | |
|---|---|---|
| What it is | Incretin receptor agonist | GHRH analogue |
| Main described target | Appetite, gastric emptying, insulin and glucagon | The pituitary's own growth hormone release |
| Acts on appetite? | Reduces it | Not usually associated with appetite change on its own |
| Effect on insulin sensitivity | Acts to improve glucose control | Growth hormone reduces insulin sensitivity |
| Weight loss in trials? | Yes, in the branded products' large trials | No |
| Schedule at Pepti | Once weekly | Monday through Friday nights |
| Human evidence | Large randomised trials | Older-adult and paediatric trials measuring hormones and laboratory endpoints |
They do not compete for the same job, which is why they are combined at all. It is also why sermorelin is not expected to make the GLP-1 work better on the scale.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
What is known about taking them together
- No trial has tested the combination. The evidence for each belongs to that medication alone.
- No trial shows lean mass is preserved. No study shows that a growth hormone secretagogue preserves lean mass during GLP-1 treatment. The pairing is grounded in mechanism and prescriber experience, which is a reasonable basis for prescribing and not evidence that it works.
- Glucose moves in opposite directions. Growth hormone raises blood glucose by reducing tissue sensitivity to insulin. In the sermorelin trials fasting glucose was unchanged, but the effect is larger in people whose glucose handling is already strained. Insulin and other glucose-lowering medications are among the drugs that touch the growth hormone axis, which is why every medication goes on the intake.
- Low blood sugar is a separate GLP-1 point. On its own tirzepatide rarely causes low blood glucose, but the risk rises with insulin or a sulfonylurea.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
The ipamorelin point
The Ipamorelin + Sermorelin vial adds ipamorelin, which acts at the ghrelin receptor, the receptor the hunger hormone uses. Sermorelin on its own is not usually associated with appetite change, but some people report more appetite on the combination. Alongside a GLP-1, that runs against what the GLP-1 is doing. It is not dangerous, but it is worth reporting if it interferes with a weight goal, and it is one reason a physician may prefer sermorelin alone.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
What not to stack
| Combination | Why not |
|---|---|
| Sermorelin with CJC-1295 or tesamorelin | Two GHRH analogues: more signal at the same receptor, not a second mechanism |
| Sermorelin with a blend that already carries a GHRH analogue, such as TITAN, ASCEND or PHYSIQ | Same receptor, and the overlap is not obvious from the name |
| Tirzepatide with semaglutide | Both act at the GLP-1 receptor; stacked side effects with no mechanism gained |
| Two of your own vials mixed in one syringe | Each label was calculated against that vial's concentration |
| Anything bought as "research use only" | Nobody is accountable for identity, purity, sterility or concentration |
Can You Take Sermorelin With Tirzepatide or Semaglutide?
Telling the side effects apart
| Symptom | More likely from | What to do |
|---|---|---|
| Nausea, reflux, constipation, diarrhoea | The GLP-1, mostly around dose increases | Message your care team if it is not settling |
| Flushing or warmth shortly after a dose | Sermorelin | Usually settles; report it if marked |
| Vivid dreams with evening dosing | Sermorelin | Report it if it persists |
| Headache in the first weeks | Either | Report it if it persists; check meals and fluids on a GLP-1 |
| Fluid retention, joint aches, tingling hands | Sermorelin; the recognised pattern of growth hormone above your requirement | Message your care team; do not change the dose yourself |
| More hunger | Ipamorelin, if you take the paired vial | Report it |
| Severe abdominal pain, often radiating to the back | The GLP-1; a possible pancreatitis presentation | Seek care |
| Facial or throat swelling, widespread rash, breathing difficulty | Either, rarely | Call 911 first, then tell your physician |
Starting sermorelin in the same week as a GLP-1 dose step makes this table harder to use. More on each is in is sermorelin safe and GLP-1 side effects.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
Semaglutide works the same way
Everything above applies to semaglutide. It acts at one incretin receptor where tirzepatide acts at two, but the reasoning for adding sermorelin is identical, and so is the glucose point. Semaglutide and tirzepatide are never taken together. The full comparison is in semaglutide vs tirzepatide.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
How to add sermorelin to a GLP-1 plan properly
- Name the gap. "I am worried about losing muscle" or "my training has stalled" gives your physician more to work with than a product name.
- List everything at intake, including any glucose-lowering medication, thyroid medication, glucocorticoid and every blend you already take.
- Start one thing at a time. Pick a start date away from a GLP-1 dose step.
- Follow each label separately. At Pepti's typical directions, sermorelin is 0.25 mL (25 units) under the skin Monday through Friday nights, 0.5 mg per dose from the 2 mg/mL vial, 20 doses per vial, about four weeks. Tirzepatide and semaglutide are once weekly. Never mix vials in one syringe.
- Keep training and protein in the plan. They are the countermeasures with the most behind them.
Your physician sets your directions after reviewing your intake, and every vial arrives with its directions printed on the label. The wider picture is in what peptides can you take with tirzepatide and can you take two peptides together.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
What the evidence shows, honestly
Tirzepatide and semaglutide have a very large human evidence base in their branded forms. Sermorelin's mechanism is well established endocrinology, and it has small trials in children with growth hormone deficiency and in healthy older adults, measuring hormone levels and laboratory endpoints. No trial has combined sermorelin with a GLP-1, and no trial shows a growth hormone secretagogue preserves lean mass during GLP-1 treatment. Anyone presenting the pairing as shown to protect muscle is overstating what exists. How sermorelin compares with its neighbours is in sermorelin vs tesamorelin vs ipamorelin, and what the research has looked at is in sermorelin benefits.
Compounded medications are not FDA approved, and compounded sermorelin is not an FDA-approved drug product. Compounded tirzepatide and semaglutide are the same active ingredients as the branded products, and the trial data belongs to the manufactured products. Tested athletes should know the 2026 WADA Prohibited List names sermorelin under S2.2.4, prohibited at all times.
Can You Take Sermorelin With Tirzepatide or Semaglutide?
Where to get sermorelin and a GLP-1 prescribed
- Complete a free online intake covering your history, medications and what you want help with.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A compounding pharmacy prepares each prescription. Lot test results are published at /quality/lab-results.
- Each vial ships refrigerated with ice packs, with sterile syringes and alcohol prep pads, and its directions printed on the vial.
- Refills run every 28 days, one vial per fill, and your care team stays reachable for questions and side effects.
Step by step: how to get sermorelin prescribed online, how to get tirzepatide prescribed online and how to get semaglutide prescribed online.
References
What this is based on.
References
- Wilding JPH, Batterham RL, Calanna S, et al.. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1) · New England Journal of Medicine (2021) · PMID 33567185
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al.. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT) · New England Journal of Medicine (2023) · PMID 37952131
- Wadden TA, Bailey TS, Billings LK, et al.. Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity (STEP 3) · JAMA (2021) · PMID 33625476
- Rubino D, Abrahamsson N, Davies M, et al.. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial · JAMA (2021) · PMID 33755728
- Marso SP, Bain SC, Consoli A, et al.. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes (SUSTAIN-6) · New England Journal of Medicine (2016) · PMID 27633186
- Davies M, Færch L, Jeppesen OK, et al.. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial · The Lancet (2021) · PMID 33667417
- Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial · Nature Medicine (2022) · PMID 36216945
- Rubino DM, Greenway FL, Khalid U, et al.. Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight in Adults With Overweight or Obesity Without Diabetes: The STEP 8 Randomized Clinical Trial · JAMA (2022) · PMID 35015037
- Aronne LJ, Horn DB, le Roux CW, et al.. Tirzepatide as Compared with Semaglutide for the Treatment of Obesity (SURMOUNT-5) · New England Journal of Medicine (2025) · PMID 40353578
- Sanyal AJ, Newsome PN, Kliers I, et al.. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis (ESSENCE) · New England Journal of Medicine (2025) · PMID 40305708
- Wilding JPH, Batterham RL, Davies M, Van Gaal LF, Kandler K et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension · Diabetes Obes Metab (2022) · PMID 35441470
- Batsis JA, Gavras A, Gross DC, Cheever CR, Da Silva BR et al.. Effect of Incretin-Based and Nonpharmacologic Weight Loss on Body Composition: A Systematic Review · Ann Intern Med (2026) · PMID 41996180
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Can You Take Sermorelin With Tirzepatide or Semaglutide?, answered.
Yes, they are sometimes prescribed together. Tirzepatide addresses appetite and weight, and some prescribers add sermorelin with lean tissue in mind. No trial has tested the combination, and glucose is watched because the two push it in opposite directions.
The same reasoning applies. Semaglutide acts at the GLP-1 receptor and sermorelin at the GHRH receptor, so they do not overlap. There is no study of the pairing.
That is the reason it is added, but no trial shows a growth hormone secretagogue preserves lean mass during GLP-1 treatment. A 16-week trial of a related GHRH analogue in older adults reported more lean mass in men only. Protein and resistance training have the most behind them.
There is no evidence that it does. Sermorelin is not a weight-loss medication, and its trials that measured body composition found no change in weight. Tirzepatide is the one with the weight-loss evidence.
Growth hormone reduces insulin sensitivity, so it can. In the published sermorelin trials fasting glucose was unchanged. Alongside a GLP-1, which acts the other way on glucose, your physician watches it across both.
The paired vial can be prescribed alongside a GLP-1. Ipamorelin acts at the ghrelin receptor, and some people report more appetite on it, which runs against what the GLP-1 is doing. Report it if it interferes with your goal.
Sermorelin and tesamorelin are both GHRH analogues, so taking them together is more signal at the same receptor rather than a second mechanism. That pairing is not used. Tesamorelin with a GLP-1 is covered in tesamorelin vs semaglutide.
Follow each label. Pepti's typical sermorelin directions are Monday through Friday nights, lining the pulse up with the body's largest natural growth hormone pulse in early sleep. Tirzepatide is once weekly. They are separate injections with separate syringes.
No. Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Anyone with an active cancer, anyone pregnant or breastfeeding, and anyone with active proliferative diabetic retinopathy. Diabetes or impaired glucose tolerance is not an automatic decline but means closer attention to glucose. Untreated sleep apnoea and thyroid problems are raised at intake. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.



